J&J 2022 net profit drops 14%: ‘Our approach to 2023 can be best described as prudent,’ says CEO 02-Feb-2023 By Kacey Culliney Personal care major Johnson & Johnson (J&J) has reported a net profit dip for the full year and last quarter of 2022 amidst ongoing macroeconomic challenges, though its CEO remains focused on heavy R&D investment.